About the Product

Description


Ranilair 25 Injection containing Ranitidine is used for the management of acidity, gastric ulcers, and related gastrointestinal conditions. It helps in reducing stomach acid production and relieving symptoms like heartburn and irritation.

Ranitidine works by blocking histamine H2 receptors in the stomach, which decreases acid secretion and promotes healing of ulcers and gastric lining.

The injection is commonly used in hospitals and emergency care where rapid acid control is required, ensuring consistent demand and repeat usage across gastro and general medicine departments.

With increasing cases of gastric disorders and continuous hospital requirement, this product offers strong business potential for distributors and stockists. Its steady prescription demand, wide application, and frequent institutional use make it a fast-moving product that can drive consistent sales and growth in the gastro segment.

Some patients may experience headache, dizziness, constipation, or diarrhea. Rarely, allergic reactions, changes in liver enzymes, or cardiac effects such as bradycardia may occur and require medical attention.

Ranilair 25 Injection is indicated for the management of peptic ulcer disease, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and for the prevention of stress ulcers in critically ill patients. It helps reduce acidity, relieve heartburn, and support healing of the gastrointestinal tract.

This injection should be administered under medical supervision. Dose adjustment may be required in patients with kidney impairment. Inform your healthcare provider about any ongoing medications to avoid interactions.

Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions